| Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration‐resistant prostate cancer TW Friedlander, VT Ngo, H Dong, G Premasekharan, V Weinberg, S Doty, ... International journal of cancer 134 (10), 2284-2293, 2014 | 138 | 2014 |
| Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients A Anantharaman, T Friedlander, D Lu, R Krupa, G Premasekharan, ... BMC cancer 16, 1-11, 2016 | 121 | 2016 |
| Looking back, to the future of circulating tumor cells TW Friedlander, G Premasekharan, PL Paris Pharmacology & therapeutics 142 (3), 271-280, 2014 | 112 | 2014 |
| Circulating tumor cells as potential biomarkers in bladder cancer A Alva, T Friedlander, M Clark, T Huebner, S Daignault, M Hussain, C Lee, ... The Journal of urology 194 (3), 790-798, 2015 | 97 | 2015 |
| Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer Y Su, Y Liu, CR Behrens, S Bidlingmaier, NK Lee, R Aggarwal, ... JCI insight 3 (17), 2018 | 49 | 2018 |
| Iron-mediated lipid peroxidation and lipid raft disruption in low-dose silica-induced macrophage cytokine production G Premasekharan, K Nguyen, J Contreras, V Ramon, VJ Leppert, ... Free Radical Biology and Medicine 51 (6), 1184-1194, 2011 | 39 | 2011 |
| An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer G Premasekharan, E Gilbert, RA Okimoto, A Hamirani, KJ Lindquist, ... Cancer Letters 380 (1), 144-152, 2016 | 28 | 2016 |
| Real-time transferrin-based PET detects MYC-positive prostate cancer R Aggarwal, SC Behr, PL Paris, C Truillet, MFL Parker, LT Huynh, J Wei, ... Molecular Cancer Research 15 (9), 1221-1229, 2017 | 22 | 2017 |
| High-dose abiraterone acetate in men with castration resistant prostate cancer TW Friedlander, JN Graff, K Zejnullahu, A Anantharaman, L Zhang, R Paz, ... Clinical Genitourinary Cancer 15 (6), 733-741. e1, 2017 | 21 | 2017 |
| Measurement of copy number variation in single cancer cells using rapid-emulsification digital droplet MDA SC Kim, G Premasekharan, IC Clark, HB Gemeda, PL Paris, AR Abate Microsystems & nanoengineering 3 (1), 1-7, 2017 | 18 | 2017 |
| Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) and white blood cells (WBCs) in muscle invasive and metastatic bladder cancer patients. A Anantharaman, TW Friedlander, D Lu, R Krupa, G Premasekharan, ... Journal of Clinical Oncology 34 (2_suppl), 446-446, 2016 | 4 | 2016 |
| Initial results from a phase II study of increased-dose abiraterone acetate in patients with castration resistant prostate cancer (CRPC). TW Friedlander, JN Graff, L Zhang, R Paz, G Premasekharan, A Dilip, ... Journal of Clinical Oncology 33 (7_suppl), 188-188, 2015 | 1 | 2015 |
| Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC). TW Friedlander, G Premasekharan, V Ngo, S Doty, A Harris, M Winter, ... Journal of Clinical Oncology 32 (4_suppl), 120-120, 2014 | 1 | 2014 |
| Abstract A153: Isolation and characterization of high-purity invasive CTCs from men with metastatic castration-resistant prostate cancer (mCRPC). G Premasekharan, TW Friedlander, VT Ngo, E Gilbert, P Sathaye, ... Molecular Cancer Therapeutics 12 (11_Supplement), A153-A153, 2013 | 1 | 2013 |
| Abstract LB-327: Isolation and mRNA-seq analysis of single CTCs from blood samples using an integrated fluidic circuit for functional single cell studies L Szpankowski, G Premasekharan, N Ramalingam, C Sanada, A Leyrat, ... Cancer Research 76 (14_Supplement), LB-327-LB-327, 2016 | | 2016 |
| Isolation and mRNA-seq analysis of single CTCs from blood samples using an integrated fluidic circuit for functional single cell studies L Szpankowski, G Premasekharan, N Ramalingam, C Sanada, A Leyrat, ... CANCER RESEARCH 76, 2016 | | 2016 |
| ERASE: Elimination of recurring artifacts and stochastic errors: An NGS analysis approach and its application to liquid biopsy samples. N Kamps-Hughes, T Tran, R Brobey, RJ Amato, AS Alva, P Paris, ... Journal of Clinical Oncology 34 (15_suppl), e13002-e13002, 2016 | | 2016 |
| Programmed death-ligand 1 characterization of circulating tumor cells and white blood cells in muscle-invasive and metastatic bladder cancer patients. TW Friedlander, D Lu, R Krupa, G Premasekharan, CJ Welty, R Paz, ... Journal of Clinical Oncology 33 (7_suppl), 353-353, 2015 | | 2015 |
| Abstract IA20: Molecular and genomic characterization of invasive circulating tumorcells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC) TW Friedlander, G Premasekharan, A Dilip, J Tawney, V Ngo, E Gilbert, ... Clinical Cancer Research 21 (4_Supplement), IA20-IA20, 2015 | | 2015 |
| Isolation and characterization of high-purity invasive CTCs from men with metastatic castration-resistant prostate cancer (mCRPC). G Premasekharan, TW Friedlander, VT Ngo, E Gilbert, P Sathaye, ... MOLECULAR CANCER THERAPEUTICS 12 (11), 2013 | | 2013 |
